David Hyman

David Hyman, CA, CBV, serves as Chief Financial Officer at Rakovina Therapeutics Inc. and Head of Finance at Medicenna Therapeutics Corp. since November 2023. Concurrently, David Hyman operates as Contract CFO for Tandem Innovation Group Inc. and previously held the CFO position at Mesentech and TheraCann International. Prior experience includes serving as CFO at Merrco Payments Inc. and Vice President at Camcor Partners. David Hyman began a career in finance as an Equity Analyst at Raymond James Financial, Inc., following a role as Senior Manager in Financial Advisory Services at Deloitte Canada. David Hyman earned a Bachelor of Commerce degree in Accounting from the University of Calgary.